Merck & Co shares up: emergency approval for corona pill and two new vaccines in India
India has granted emergency approval to Merck & Co’s corona tablet (molnupiravir) and the Covovax and Corbevax vaccines.
The drug and the vaccines are to be manufactured in India, Health Minister Mansukh Mandaviya announced on Twitter on Tuesday.
So far, the locally produced AstraZeneca vaccine Covishield, as well as Covaxin, Sputnik V, Moderna and Johnson & Johnson have been approved in India. The country is known as the pharmacy of the world and generally produces a large part of the vaccines worldwide – especially for poorer countries.
India recently gave the green light to booster shots for the elderly as well as vaccinations for children. The corona numbers in the country are still low. Many people have some immunity from having gone through illness or being vaccinated.
Merck & Co shares ultimately gained 0.34 percent on the NYSE to $ 76.83.